Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04808 |
| Species: | Homo sapiens |
| Position : | chr1:230293530-230305966 |
| Year: | 2016 |
| Title: | Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 26817450 |
| Tissue: | liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | Hep G2 |
| CVCL ID: | CVCL_0027 |
| Cell Type: | hepatocyte |
| Cell Ontology ID: | CL:0000182 |
| Experiment Type: | Enhancer activity assay; TF-binding/chromatin assay; Genetic-variant functional analysis |
| High Throughput Method: | ChIP-seq; GWAS/genetic association |
| Low Throughput Method: | Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; EMSA/gel-shift assay |
| Target gene : | GALNT2 |
| TF name : | ZBTB3 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04796 | chr1:230294600-230294900 | liver | malignant cell | NA |
| E_04797 | chr1:230294600-230294900 | liver | malignant cell | NA |
| E_04798 | chr1:230294600-230294900 | liver | malignant cell | NA |
| E_04799 | chr1:230294600-230294900 | liver | malignant cell | NA |
| E_04807 | chr1:230294600-230294900 | liver | malignant cell | NA |